Psychological distress in cancer patients assessed with an expert rating scale

P Herschbach, K Book, T Brandl, M Keller, G Lindena, K Neuwöhner, B Marten-Mittag, P Herschbach, K Book, T Brandl, M Keller, G Lindena, K Neuwöhner, B Marten-Mittag

Abstract

The purpose of this study was to investigate psychosocial stress in a large sample of cancer patients using an expert rating scale. Specific aims were to analyse the relevance of setting variables (type of clinic, contact initiative, therapy) and gender. A total of 6365 patients were assessed in 105 institutions. Univariate and multivariate statistical analysis of setting variables indicated that patients treated in palliative care settings showed highest distress scores compared to patients recruited from hospitals and outpatient clinics (P<0.001). Significant differences were also found for contact initiative (P<0.001); lowest distress was found in patients who were recruited by routine contact. Patients who asked for psychosocial support or who were recruited by the medical staff showed the highest distress scores. The analysis of therapy groups showed that patients receiving radiotherapy or surgery were not more distressed than patients without therapy. The most distressing treatment was chemotherapy. Gender had differential effects on clinic type (P<0.001) and contact initiative (P<0.001) but not on treatment and diagnosis. Expert rating scales are an important complement for self-assessment questionnaires to evaluate psychological distress of cancer patients in psychosocial studies as well as in routine medical care.

Figures

Figure 1
Figure 1
Distress scores of PO-Bado single items for male (solid line) and female patients.

References

    1. Aaronson NK, the EORTC QoL-study-group (1991) The EORTC core quality of life questionnaire. In Effect of Cancer on QoL, Osoba D (ed) pp 185–203. CRC Press: Vancouver
    1. Bultz BD, Carlson LE (2006) Emotional distress: the sixth vital sign–future directions in cancer care. Psycho-Oncology 15: 93–95
    1. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3): 570–579
    1. Derogatis LR (1993) The Brief Symptom Inventory (BSI): Administration, Scoring and Procedures Manual. MN National Computer Systems: Minneapolis, MN
    1. Ford S, Lewis S, Fallowfield L (1995) Psychological morbidity in newly referred patients with cancer. J Psychosom Res 39: 193–202
    1. Goldberg D, Williams P (1988) A User's Guide to the General Health Questionnaire. NFER-Nelson: Windsor
    1. Härter M, Reuter K, Aschenbrenner A, Schretzmann B, Marschner N, Hasenburg A, Weis J (2001) Psychiatric disorders and associated factors in cancer: results of an interview study with patients in inpatient, rehabilitation and outpatient treatment. Eur J Cancer 37(11): 1385–1393
    1. Herschbach P, Brandl T, Knight L, Keller M (2004b) Einheitliche Beschreibung des subjektiven Befindens von Krebskranken. Entwicklung einer psychoonkologischen Basisdokumentation (PO-Bado). Deutsches Ärzteblatt 101(12): 799–802
    1. Herschbach P, Keller M, Knight L, Brandl T, Huber B, Henrich G, Marten-Mittag B (2004a) Psychological problems of cancer patients: a cancer distress screening with a cancer-specific questionnaire. Br J Cancer 91: 504–511
    1. Herschbach P (2002) Das ‘Zufriedenheitsparadox’ in der Lebensqualitätsforschung – wovon hängt unser Wohlbefinden ab? Psychother Psychosom Med Psychol 52: 141–150
    1. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L (1994) Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 30A(1): 37–40
    1. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH (1948) The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1: 634–656
    1. Knight L, Mussell M, Brandl T, Herschbach P, Marten-Mittag B, Treiber M, Keller M (2008) Development and psychometric evaluation of the basic documentation for Psycho-Oncology (PO-Bado), a tool for standardized assessment of cancer patients. J Psychosom Res 64(4): 373–381
    1. Lindena G, Nauck F, Bausewein C, Neuwöhner K, Heine O, Schulenberg D, Radbruch L (2005) Qualitätssicherung in der Palliativmedizin – Ergebnisse der Kerndokumentation 1999–2002. Z Evid Fortbild Qual Gesundh Wesen 99: 555–565
    1. Payne DK, Hoffman RG, Theodoulou M, Dosik M, Massie MJ (1999) Screening for anxiety and depression in women with breast cancer. Psychosomatics 40: 64–69
    1. Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher H, Holland JC (1998) Rapid screening of psychologic distress in men with prostate carcinoma. A pilot study. Cancer 82(10): 1904–1908
    1. Sellick SM, Edwardson AD (2007) Screening new cancer patients for psychological distress using the hospital anxiety and depression scale. Psycho-Oncology 16: 534–542
    1. Spilker B (ed) (1990) Quality of Life Assessments in Clinical Trials. Raven Press: New York
    1. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR (1981) Measuring the quality of life of cancer patients. A concise QL-Index for use by physicians. J Chron Dis 34: 585–597
    1. Van't Spijker A, Trijsburg RW, Duivenvoorden HJ (1997) Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 59: 280–293
    1. Vos MS, de Haes JCJM (2007) Denial in cancer patients, an explorative review. Psycho-Oncology 16: 12–25
    1. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psycho-Oncology 10: 19–28
    1. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361–370

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe